1,2-distearoyllecithin has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunte, RM; Chiu, GN; Chng, WJ; Ling, LU; Tan, KB | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Ceramides; Cholesterol; Chromatography, Liquid; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, SCID; Phosphatidylcholines; Sphingosine; Tandem Mass Spectrometry; U937 Cells; Xenograft Model Antitumor Assays | 2014 |